san antonio breast cancer symposium 2008: poor prognosis on small, her2 positive tumours
Published 14 years ago • 629 plays • Length 3:56Download video MP4
Download video MP3
Similar videos
-
5:25
san antonio breast cancer symposium 2008: zoledronic acid may have anti-tumour properties
-
5:17
san antonio breast cancer symposium 2008: use of written forms doubles breast cancer detection rate
-
15:44
pd8 spotlight session 8 her2 positive breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
16:06
pd8 spotlight session 8 her2 positive breast cancer
-
0:49
san antonio breast cancer symposium 2022 highlights
-
15:50
spotlight session 8 her2 positive breast cancer novel therapies for her2 advanced breast cancer
-
1:00
highlights from the san antonio breast cancer symposium 2022
-
2:26
effect of trastuzumab-based therapy on survival in small, node-negative her2-positive breast cancer
-
1:01:35
her2 treatment
-
9:05
pertuzumab plus trastuzumab and chemotherapy continues to show benefit in her2-positive breast c...
-
2:57
key data from the san antonio breast cancer symposium (sabcs) 2022
-
46:19
dr. giuseppe curigliano | san antonio breast cancer symposium 2022
-
0:56
remaining questions on the management of her2-low breast cancer
-
1:42:44
education session her2 breast cancer updates from the clinic and the lab
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
4:53
report from 2011 san antonio breast cancer symposium | dana-farber cancer institute
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
35:20
natalie marshall | 2017 san antonio breast cancer symposium